Fueled by a $1.05 million award from the Chan Zuckerberg Initiative, a Belgian team plans to build patient-derived 2-D chips to model human neuronal microcircuits in Parkinson's disease. The chips would help stratify patient subgroups and screen new therapies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,